Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1

Conditions

Squamous Intraepithelial Lesions 1Skin Neoplasms 1Precancerous Conditions 1Papillomavirus Infections 1Papilloma 1Lung Neoplasms 1Laryngeal papillomatosis 1Keratosis, Actinic 1Hyperthermia 1HIV Infections 1Cicatrix 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1Anus Neoplasms 1Acquired Immunodeficiency Syndrome 1

Interventions

Etoposide 4Cyclophosphamide 4Vincristine 3Specimen Handling 3Prednisone 3Magnetic Resonance Spectroscopy 3Doxorubicin 3Biopsy 3fludarabine phosphate 2cabozantinib 2Whole-Body Irradiation 2Watchful Waiting 2Rituximab 2Polymerase Chain Reaction 2Peripheral Blood Stem Cell Transplantation 2Nivolumab 2Light Coagulation 2Imiquimod 2Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 2Gene Expression Profiling 2Fluorouracil 2technetium-diethylenetriaminepentaacetic acid-mannosyl-dextran 1prednylidene 1pembrolizumab 1fludarabine 1emvododstat 1efineptakin alfa 1deltacortene 1carmustine, poliferprosan 20 drug combination 1Vorinostat 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × HIV Infections × Laser Therapy × Clear all
NCT02135419 2024-07-26

ANCHOR

AIDS Malignancy Consortium

Phase 3 Completed
4,446 enrolled 13 charts
GastrointestinalGynecologic

Squamous Intraepithelial Lesions, Acquired Immunodeficiency Syndrome, Anus Neoplasms, HIV Infections, Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡